6 recruiting, 5 unknown, 3 active not recruiting, 3 completed. 19 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 19 | Recruiting 6, Unknown 5, Active not recruiting 3, Completed 3, Terminated 2 |
Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors INN805 - Maligant Solid Tumor, Head & Neck Cancer | Early Phase 1 | Recruiting | FindCure Biosciences (ZhongShan) Co., Ltd. | 10 | 2026-04-20 | 2026-09-04 |
| In Vivo CAR-T for Refractory Graves' Disease In Vivo CAR-T Therapy - Graves' Disease | Early Phase 1 | Recruiting | Shanghai Zhongshan Hospital | 5 | 2026-01-29 | 2026-03-19 |
| Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease allogenic anti-CD19/BCMA CAR-T - Graves' Disease | Early Phase 1 | Recruiting | Shanghai Zhongshan Hospital | 4 | 2025-12-19 | 2026-01-05 |
| Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease Allogeneic CAR-T - Graves Disease | Early Phase 1 | Recruiting | Shanghai Zhongshan Hospital | 5 | 2025-08-10 | 2025-08-19 |
| Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer 177Lu-LNC1004 Injection - Radioiodine Refractory Differentiated Thyroid Cancer | Early Phase 1 | Recruiting | Peking Union Medical College Hospital | 20 | 2025-03-24 | 2025-04-15 |
| Clinical Efficacy of Darqeen Capsule for the Management of Hypothyroidism Associated with Female Reproductive Hormonal Imbalance Darqeen Capsule - Hypothyroidism | Early Phase 1 | Active not recruiting | Hamdard University | 50 | 2024-07-02 | 2025-02-13 |
| MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin Dapagliflozin 10mg Tab, Placebo, Levothyroxine Replacement daily - Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease | Early Phase 1 | Active not recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 50 | 2024-01-15 | 2026-08-28 |
| Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy. Rapamycin, Methylprednisolone - Graves Ophthalmopathy | Early Phase 1 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 140 | 2022-09-01 | 2022-09-08 |
| Vit D Role in Post Thyroidectomy Hypocalcemia vit D - Thyroid Diseases | Early Phase 1 | Unknown | Assiut University | 30 | 2019-10-01 | 2019-09-19 |
| Exparel Injection Effect on Postoperative Opioid Usage Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine, Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine - Thyroid, Parathyroid Adenoma | Early Phase 1 | Unknown | University of Missouri-Columbia | 100 | 2019-09-30 | 2024-07-29 |
| the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism Probiotic - Microbiota | Early Phase 1 | Unknown | First Affiliated Hospital of Harbin Medical University | 30 | 2018-05-01 | 2018-07-16 |
| Bimatoprost as a Treatment for Graves' Orbitopathy Bimatoprost Ophthalmic - Graves Ophthalmopathy | Early Phase 1 | Recruiting | Johns Hopkins University | 3 | 2017-11-01 | 2026-07-16 |
| RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers Durvalumab (Medi4736), Radioiodine (RAI) - Thyroid Cancer | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 11 | 2017-07-10 | 2026-08-11 |
| Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study Vemurafenib, serial 124I PET/CT, thyrotropin alpha - Thyroid Carcinoma | Early Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 12 | 2014-05-20 | 2025-06-18 |
| BRAF V600E Mutations In Papillary Thyroid Carcinoma BRAF V600E POSITIVITY - Papillary Thyroid Carcinoma | Early Phase 1 | Unknown | Bezmialem Vakif University | 150 | 2011-07-01 | 2011-08-16 |
| Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics Administration of stable Isotope labeled levothyroxine - Hypothyroidism Primary | Early Phase 1 | Completed | Georgetown University | 41 | 2011-05-31 | 2017-04-06 |
| A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression Bexarotene - Thyroid Cancer | Early Phase 1 | Completed | University of Colorado, Denver | 10 | 2008-11-01 | 2014-01-17 |
| DIM as a Treatment for Thyroid Disease Diindolylmethane (DIM) - Proliferative Thyroid Disease | Early Phase 1 | Terminated | The New York Eye & Ear Infirmary | 7 | 2006-11-01 | 2013-05-03 |
| High Intensity Focused Ultrasound Device in Patients With Autonomous Hyperfunctioning Thyroid Nodules HIFU - Autonomous Hyperfunctioning Thyroid Nodules | Early Phase 1 | Terminated | Theraclion | 2 | 2006-06-01 | 2014-06-23 |
Thyroid Neoplasms (6) · Graves Disease (3) · Hypothyroidism (3) · Aggression (2) · Graves Ophthalmopathy (2) · Breast Neoplasms (1) · Head and Neck Neoplasms (1) · Heterotaxy Syndrome (1) · Infertility, Female (1) · Non-alcoholic Fatty Liver Disease (1) · Parathyroid Neoplasms (1) · Sarcoma (1) · Thyroid Cancer, Papillary (1)
Endocrine System Diseases (19) · Endocrine Gland Neoplasms (8) · Neoplasms (8) · Neoplasms by Site (8) · Head and Neck Neoplasms (7) · Autoimmune Diseases (5) · Exophthalmos (5) · Eye Diseases (5) · Goiter (5) · Hyperthyroidism (5) · Immune System Diseases (5) · Orbital Diseases (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Aberrant Motor Behavior in Dementia (2)
3,3'-diindolylmethane (1) · Bexarotene (1) · Iodine-131 (1) · Methylprednisolone (1) · Probiotics (1) · Sirolimus (1) · Thyrotropin Alfa (1) · Thyroxine (1) · Vemurafenib (1) · dapagliflozin (1) · durvalumab (1)
Shanghai Zhongshan Hospital (3) · Memorial Sloan Kettering Cancer Center (2) · Assiut University (1) · Bezmialem Vakif University (1) · FindCure Biosciences (ZhongShan) Co., Ltd. (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · First Affiliated Hospital of Harbin Medical University (1) · Georgetown University (1) · Hamdard University (1) · Johns Hopkins University (1) · Peking Union Medical College Hospital (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · The New York Eye & Ear Infirmary (1) · Theraclion (1) · University of Colorado, Denver (1)
China (7) · United States (6) · Egypt (1) · France (1) · India (1) · Pakistan (1) · Turkey (Türkiye) (1)
Alan Ho, MD, PhD (1) · Alan L. Ho, MD, PhD (1) · Ashu Rastogi, MD,DM (1) · Bingyin Shi (1) · Emily Li, MD (1) · Joshua Klopper, MD (1) · Stimson P. Schantz, MD (1) · Tabitha Galloway, MD (1) · Xiaoying LI, MD, PhD (1) · Yunwei Wei (1)
PMID 23140919, PMID 26365947, PMID 30256977, PMID 30813146, PMID 31492617, PMID 31494332, PMID 35350100